Samuel Orkin Freedman, OC CQ FRSC (born May 8, 1928) is a Canadian clinical immunologist, professor and academic administrator. In 1965, he co-discovered with Phil Gold the carcinoembryonic antigen, the basis of a blood test used in the diagnosis and management of people with colorectal cancer.

Samuel O. Freedman
Occupation(s)Immunologist, professor

Background edit

Born in Montreal, Freedman received a Bachelor of Science in 1948 and a Doctor of Medicine in 1953 from McGill University.[1]

Career edit

From 1977 to 1981, he was the Dean of the McGill University Faculty of Medicine. From 1981 to 1991, he served as McGill's chief academic officer with the title of Vice-Principal, Academic (equivalent to Provost at U.S. universities). Freedman received an honorary degree from McGill in 1992. He was named Professor Emeritus in 2000.[2] Until January 1, 2008, Freedman was senior advisor to the Sir Mortimer B. Davis Jewish General Hospital in Montreal, where he was previously research director.

Book edit

  • Freedman, Samuel O.; Gold, Phil (1976). Clinical Immunology. Hagerstown, Md.: Harper & Row. ISBN 0-06-140834-4 OCLC 2189449; 1st edition. Harper & Row. 1971. ISBN 0-06-140831-X.[3]

Research publications edit

  • Gold, Phil; Freedman, Samuel O. (1965-03-01). "Demonstration of Tumor-Specific Antigens in Human Colonic Carcinomata by Immunological Tolerance and Absorption Techniques". Journal of Experimental Medicine. Rockefeller University Press. 121 (3): 439–462. doi:10.1084/jem.121.3.439 ISSN 1540-9538.

Honours edit

References edit

External links edit

Academic offices
Preceded by Dean of the McGill University Faculty of Medicine
1977-1981
Succeeded by